Scholarly Index
Andreas K. Buck
Universitätsklinikum Würzburg; 24,190 total citations; 595 total publications; best world rank #9
Universitätsklinikum Würzburg
24,190Total citations
595Total publications
85H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Medical Imaging Techniques and Applications | Lifetime | 80 | DE 8 | 99.42 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 233 | DE 19 | 99.11 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 183 | DE 23 | 98.70 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 801 | DE 64 | 98.07 |
| Neuroendocrine Tumor Research Advances | Lifetime | 566 | DE 41 | 98.13 |
| Lymphoma Diagnosis and Treatment | Lifetime | 903 | DE 82 | 97.96 |
| Multiple Myeloma Research and Treatments | Lifetime | 466 | DE 28 | 97.58 |
| Medical Imaging and Pathology Studies | Lifetime | 575 | DE 20 | 97.22 |
| Chemokine receptors and signaling | Lifetime | 283 | DE 24 | 95.81 |
| Chemokine receptors and signaling | 2021-2025 | 9 | DE 3 | 96.01 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 122 | DE 21 | 96.77 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 425 | DE 27 | 96.28 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 394 | DE 23 | 92.53 |
| Prostate Cancer Treatment and Research | 2021-2025 | 643 | DE 66 | 94.52 |
| Lung Cancer Research Studies | 2021-2025 | 761 | DE 19 | 91.74 |
| Peptidase Inhibition and Analysis | 2021-2025 | 841 | DE 82 | 87.29 |